Results
|
|
41.
|
|
|
|
42.
|
|
|
|
43.
|
Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy. [electronic resource] by
- Veldt, B J
- Saracco, G
- Boyer, N
- Cammà, C
- Bellobuono, A
- Hopf, U
- Castillo, I
- Weiland, O
- Nevens, F
- Hansen, B E
- Schalm, S W
Producer: 20041129
In:
Gut vol. 53
Availability: No items available.
|
|
|
44.
|
|
|
|
45.
|
|
|
|
46.
|
|
|
|
47.
|
|
|
|
48.
|
|
|
|
49.
|
|
|
|
50.
|
|
|
|
51.
|
Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: analysis of individual patient data of six controlled trials. Eurohep Study Group for Viral Hepatitis. [electronic resource] by
- Schalm, S W
- Weiland, O
- Hansen, B E
- Milella, M
- Lai, M Y
- Hollander, A
- Michielsen, P P
- Bellobuono, A
- Chemello, L
- Pastore, G
- Chen, D S
- Brouwer, J T
Producer: 19990826
In:
Gastroenterology vol. 117
Availability: No items available.
|
|
|
52.
|
Relapse after treatment with peginterferon alpha-2b alone or in combination with lamivudine in HBeAg positive chronic hepatitis B. [electronic resource] by
- Flink, H J
- Buster, E H C J
- Merican, I
- Nevens, F
- Kitis, G
- Cianciara, J
- de Vries, R A
- Hansen, B E
- Schalm, S W
- Janssen, H L A
Producer: 20071105
In:
Gut vol. 56
Availability: No items available.
|
|
|
53.
|
|
|
|
54.
|
Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice. [electronic resource] by
- Andersson, E C
- Hansen, B E
- Jacobsen, H
- Madsen, L S
- Andersen, C B
- Engberg, J
- Rothbard, J B
- McDevitt, G S
- Malmström, V
- Holmdahl, R
- Svejgaard, A
- Fugger, L
Producer: 19980806
In:
Proceedings of the National Academy of Sciences of the United States of America vol. 95
Availability: No items available.
|
|
|
55.
|
Loss of intrahepatic HBsAg expression predicts sustained response to peginterferon and is reflected by pronounced serum HBsAg decline. [electronic resource] by
- Arends, P
- Rijckborst, V
- Zondervan, P E
- Buster, E
- Cakaloglu, Y
- Ferenci, P
- Tabak, F
- Akarca, U S
- Simon, K
- Sonneveld, M J
- Hansen, B E
- Janssen, H L A
Producer: 20150707
In:
Journal of viral hepatitis vol. 21
Availability: No items available.
|
|
|
56.
|
|
|
|
57.
|
|
|
|
58.
|
Reduced risk of relapse after long-term nucleos(t)ide analogue consolidation therapy for chronic hepatitis B. [electronic resource] by
- Chi, H
- Hansen, B E
- Yim, C
- Arends, P
- Abu-Amara, M
- van der Eijk, A A
- Feld, J J
- de Knegt, R J
- Wong, D K H
- Janssen, H L A
Producer: 20150715
In:
Alimentary pharmacology & therapeutics vol. 41
Availability: No items available.
|
|
|
59.
|
Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase. [electronic resource] by
- van Nunen, A B
- Hansen, B E
- Suh, D J
- Löhr, H F
- Chemello, L
- Fontaine, H
- Heathcote, J
- Song, B C
- Janssen, H L A
- de Man, R A
- Schalm, S W
Producer: 20030411
In:
Gut vol. 52
Availability: No items available.
|
|
|
60.
|
Peginterferon add-on results in more HBsAg decline compared to monotherapy in HBeAg-positive chronic hepatitis B patients. [electronic resource] by
- Brouwer, W P
- Sonneveld, M J
- Xie, Q
- Guo, S
- Zhang, N
- Zeuzem, S
- Tabak, F
- Zhang, Q
- Simon, K
- Akarca, U S
- Streinu-Cercel, A
- Hansen, B E
- Janssen, H L A
Producer: 20171101
In:
Journal of viral hepatitis vol. 23
Availability: No items available.
|